Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Avenu Medical, Inc. has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are both located within 1 distinct art unit, suggesting a concentrated technical focus for the company's current patenting efforts. However, the prosecution involves 2 distinct examiners, meaning each pending action is being reviewed by a different official. This combination of a single art unit and multiple examiners requires the applicant to be mindful of how different individuals within the same specialized group might interpret similar technical disclosures.
KALIHER, HANS CHRISTIAN is the busiest examiner for Avenu Medical, Inc., with 1 pending office action. This represents a portion of the 2 pending actions for the portfolio. Practitioners can expect a consistent art unit environment but must manage the individual preferences of the distinct examiners currently assigned to the company's cases. Because there are distinct examiners for the pending office actions, the company faces a unique review for every active matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (67%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BORSCH, NICHOLAS S | 1 | 72.9% | +12.1% |
| KALIHER, HANS CHRISTIAN | 1 | 62.9% | +27.3% |
| DELLA, JAYMI E | 1 | 68.8% | +29.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19084330 | Systems and Methods for Percutaneous Access, Formation, and Maintenance of Arteriovenous Fistulas | BORSCH, NICHOLAS S | — |
| 18953050 | VASCULAR FLOW CONTROL DEVICES AND METHODS | KALIHER, HANS CHRISTIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18320817 | SYSTEMS AND METHODS FOR CREATING ARTERIOVENOUS (AV) FISTULAS | DELLA, JAYMI E | 56d |
| 19084330 | Systems and Methods for Percutaneous Access, Formation, and Maintenance of Arteriovenous Fistulas | BORSCH, NICHOLAS S | — |
| 18953050 | VASCULAR FLOW CONTROL DEVICES AND METHODS | KALIHER, HANS CHRISTIAN | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19084330 | Systems and Methods for Percutaneous Access, Formation, and Maintenance of Arteriovenous Fistulas | BORSCH, NICHOLAS S | — | §102§103Other | Non-Final OA | — | Pending | Mar 19, 2025 |
| 18953050 | VASCULAR FLOW CONTROL DEVICES AND METHODS | KALIHER, HANS CHRISTIAN | — | §102§103 | Non-Final OA | — | Pending | Nov 19, 2024 |
| 18320817 | SYSTEMS AND METHODS FOR CREATING ARTERIOVENOUS (AV) FISTULAS | DELLA, JAYMI E | 3794 | Other | Final Rejection | 56d | Pending | May 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial